Febuxostat for the treatment of gout.

about

Kidney Disease in Adenine Phosphoribosyltransferase Deficiency.Acute kidney injury observed during phase 1 clinical trials of a novel xanthine oxidase/URAT1 dual inhibitor PF-06743649.Physiology of Hyperuricemia and Urate-Lowering Treatments.

P2860

Q36762992-977DEBF6-3F13-485D-9C0F-F06D0702B388 Q53162240-56850E53-FEE0-4412-9FEA-B949B50E28EA Q55163806-E2928463-2D45-4E37-ABC1-34731C5E4BB9

P2860

Febuxostat for the treatment of gout.

Item

http://www.wikidata.org/entity/Q38306517

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Febuxostat for the treatment of gout.

@en

type

Item

label

Febuxostat for the treatment of gout.

@en

prefLabel

Febuxostat for the treatment of gout.

@en

P1476

Febuxostat for the treatment of gout.

@en

P2093

Benjamin Chavez

http://www.w3.org/2001/XMLSchema#string

P2860

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

Febuxostat compared with allopurinol in patients with hyperuricemia and gout.

Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.

Febuxostat: a new treatment for hyperuricaemia in gout.

Efficacy and tolerability of febuxostat in hyperuricemic patients with or without gout: a systematic review and meta-analysis.

Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Cardiovascular thromboembolic events associated with febuxostat: investigation of cases from the FDA adverse event reporting system database.

P304

395-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.985588

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mary Bridgeman

P577

2015-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25556668

http://www.w3.org/2001/XMLSchema#string

Febuxostat for the treatment of gout.

about

P2860

P2860

Febuxostat for the treatment of gout.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698